Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma

内质网应激在原发性开角型青光眼发病机制中的作用

基本信息

  • 批准号:
    8383990
  • 负责人:
  • 金额:
    $ 8.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Primary open angle glaucoma (POAG), the most common form of glaucoma, is usually accompanied by elevated intraocular pressure (IOP) due to failure of the trabecular meshwork (TM) to maintain normal levels of aqueous humor outflow. We recently generated a novel transgenic murine model (Tg-MYOCY437H) that expresses mutant myocilin, a known leading genetic cause of POAG in humans and replicates human glaucoma phenotypes. Importantly, we have associated endoplasmic reticulum (ER) stress to the pathogenesis of glaucoma in Tg-MYOCY437H mice. Misfolded myocilin accumulates in the ER, induces ER stress and activates a protective unfolded protein response (UPR). Along with UPR activation, mutant myocilin also induces autophagy, a process of lysosomal degradation known to degrade protein aggregates. However, failure to eliminate myocilin aggregates possibly due to insufficient UPR and impaired autophagy, TM cells induce the ER stress-initiated apoptotic transcriptional factor, Chop, which may further worsen ER homeostasis and cause TM dysfunction/loss, elevating IOP and resulting in POAG. The current proposal will further investigate the role of chronic ER stress in the pathogenesis of myocilin as well as non-myocilin associated POAG. During the mentored phase, the proposed studies will determine whether failure to activate the protective UPR (Atf-6¿-/-) exacerbates glaucoma phenotypes, whereas interference with ER stress-induced apoptosis (Chop-/-) prevents glaucoma in Tg-MYOCY437H mice. In addition, we will investigate whether ER stress is activated in port-mortem TM tissues from POAG donors. During the independent phase, we will examine whether induction of ER stress in the TM is associated with elevation of IOP in a mouse model of dexamethasone-induced ocular hypertension. In addition, we will examine the role of autophagy in degradation of myocilin aggregates and will determine whether inducing autophagy by rapamycin will rescue the glaucoma of Tg-MYOCY437H mice. Specifically, the candidate will learn and generate new models of ER stress using Atf6¿ and Chop knockout mice, generate induced pluripotent stem cells (iPSCs)-derived trabecular meshwork- like cells from POAG patients, and characterize a dexamethasone-induced ocular hypertension mouse model in the laboratory of Dr. Val Sheffield. Additionally, during the mentored phase, the candidate will continue his professional and scientific career development through continual guidance from the advisory committee. He will attend scientific conferences, and collaborate with ER stress expert, Dr. Thomas Rutkowski and glaucoma clinical expert, Dr. Lee Alward. He will also acquire teaching experience. This project will facilitate continued technical, intellectul, and professional training of the candidate, and assist the candidate in the establishment of an independent research laboratory at an academic research institute. PUBLIC HEALTH RELEVANCE: The successful completion of this project will lead to insight into elevated intraocular pressure, a major risk factor of the human blinding disorder, primary open angle glaucoma. The results will potentially improve diagnosis, genetic risk assessment and treatment of this common disorder.
描述(申请人提供):原发性开角型青光眼(POAG)是最常见的青光眼形式,由于小梁网(TM)未能维持正常的房水流出水平,通常伴随高眼压(IOP)。我们最近建立了一种新的转基因小鼠模型(TG-MYOCY437H),该模型表达突变的myoclin,这是已知的人类POAG的主要遗传原因,并复制了人类青光眼的表型。重要的是,我们发现内质网应激与TG-MYOCY437H小鼠青光眼的发病机制有关。错误折叠的肌球蛋白在内质网中积聚,诱导内质网应激,并激活保护性未折叠蛋白反应(UPR)。在UPR激活的同时,突变的myocin还诱导自噬,这是一个已知的降解蛋白质聚集体的溶酶体降解过程。然而,由于UPR不足和自噬功能受损,TM细胞不能清除myocin聚集体,从而诱导内质网应激启动的凋亡转录因子CHOP,这可能进一步恶化内质网稳态,导致TM功能障碍/丢失,升高眼压,导致POAG。目前的建议将进一步研究慢性内质网应激在霉菌素相关的POAG和非霉菌素相关性POAG的发病机制中的作用。在指导阶段,拟议的研究将确定未能激活保护性UPR(ATF-6-/-)是否会加剧青光眼表型,而干扰内质网应激诱导的细胞凋亡(CHOP-/-)则可以预防TG-MYOCY437H小鼠的青光眼。此外,我们还将调查POAG供者的临死TM组织中是否存在内质网应激。在独立阶段,我们将检验在地塞米松诱导的高眼压小鼠模型中,TM内质网应激的诱导是否与眼压升高有关。此外,我们将研究自噬在霉菌素聚集体降解中的作用,并将确定用雷帕霉素诱导自噬是否可以挽救TG-MYOCY437H小鼠的青光眼。具体地说,候选人将利用ATF6和CHOP基因敲除小鼠学习并产生新的ER应激模型,从POAG患者中产生诱导多能干细胞(IPSCs)来源的小梁网状细胞,并在Val Shefffield博士的实验室中鉴定地塞米松诱导的高眼压小鼠模型。此外,在指导阶段,候选人将通过咨询委员会的持续指导继续其专业和科学的职业发展。他将出席科学会议,并与ER压力专家Thomas Rutkowski博士和青光眼临床专家Lee Alward博士合作。他还将获得教学经验。该项目将促进候选人继续接受技术、知识和专业培训,并协助候选人在学术研究机构建立独立的研究实验室。 公共卫生相关性:该项目的成功完成将有助于深入了解眼压升高,这是人类致盲障碍--原发性开角型青光眼的主要风险因素。这一结果可能会改善这种常见疾病的诊断、遗传风险评估和治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gulab Zode其他文献

Gulab Zode的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gulab Zode', 18)}}的其他基金

Development and characterization of an inducible model for myocilin POAG
肌纤蛋白 POAG 诱导模型的开发和表征
  • 批准号:
    10661911
  • 财政年份:
    2023
  • 资助金额:
    $ 8.77万
  • 项目类别:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
使用 4-苯基丁酸钠靶向 ER 应激通路治疗 POAG
  • 批准号:
    10202609
  • 财政年份:
    2018
  • 资助金额:
    $ 8.77万
  • 项目类别:
Targeting ER Stress Pathway Using Sodium 4-Phenylbutyrate for the Treatment of POAG
使用 4-苯基丁酸钠靶向 ER 应激通路治疗 POAG
  • 批准号:
    9788452
  • 财政年份:
    2018
  • 资助金额:
    $ 8.77万
  • 项目类别:
Crosstalk Between Unfolded Protein Response and Autophagy for the Treatment of Glaucoma
未折叠蛋白反应与自噬之间的串扰用于治疗青光眼
  • 批准号:
    9124324
  • 财政年份:
    2016
  • 资助金额:
    $ 8.77万
  • 项目类别:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
慢性 ER 应激与线粒体自噬治疗 POAG 之间的串扰
  • 批准号:
    10850091
  • 财政年份:
    2016
  • 资助金额:
    $ 8.77万
  • 项目类别:
Crosstalk between chronic ER stress and mitophagy for the treatment of POAG
慢性 ER 应激与线粒体自噬治疗 POAG 之间的串扰
  • 批准号:
    10445174
  • 财政年份:
    2016
  • 资助金额:
    $ 8.77万
  • 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
  • 批准号:
    8822297
  • 财政年份:
    2014
  • 资助金额:
    $ 8.77万
  • 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
  • 批准号:
    8813843
  • 财政年份:
    2014
  • 资助金额:
    $ 8.77万
  • 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
  • 批准号:
    9039612
  • 财政年份:
    2014
  • 资助金额:
    $ 8.77万
  • 项目类别:
Role of ER Stress in the Pathogenesis of Primary Open Angle Glaucoma
内质网应激在原发性开角型青光眼发病机制中的作用
  • 批准号:
    8534133
  • 财政年份:
    2012
  • 资助金额:
    $ 8.77万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10596657
  • 财政年份:
    2021
  • 资助金额:
    $ 8.77万
  • 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10417219
  • 财政年份:
    2021
  • 资助金额:
    $ 8.77万
  • 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
  • 批准号:
    nhmrc : 1059331
  • 财政年份:
    2014
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
  • 批准号:
    251802
  • 财政年份:
    2012
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
  • 批准号:
    191299
  • 财政年份:
    2009
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    8075522
  • 财政年份:
    2009
  • 资助金额:
    $ 8.77万
  • 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    7676912
  • 财政年份:
    2009
  • 资助金额:
    $ 8.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了